Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Olier

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal D'Urologie Et De Nephrologie|June 1, 1973
[Ureteral compressions in Crohn's disease]C Olier, M Malafosse, M Huguier, et al.
Annales D'Urologie|January 1, 1985
[Ureteral invagination caused by a fibroepithelial polyp of the ureter. Apropos of a case]S Haupert, A Janin-Mercier, L Camillieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Drug-induced thrombocytopenia induced by trastuzumab: a special challenge in a curable diseaseC Jara Sánchez, C Olier Gárate, J García-Donas Jiménez, et al.
Annales D'Urologie|January 1, 1985
[Ureteral endometriosis. Apropos of a bilateral form]S Haupert, A Janin-Mercier, S Martini, et al.
Journal D'Urologie Et De Nephrologie|June 1, 1973
[A further case of arteriovenous fistula of the renal pedicle after nephrectomy]L B Gibod, C Olier, J L Giraudel, et al.
Anales Del Sistema Sanitario De Navarra|January 30, 2008
[New treatments for renal carcinoma]J L Pérez-Gracia, J M López-Picazo, C Olier, et al.
Scientific Reports|February 20, 2021
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancerI Blancas, C Olier, V Conde, et al.
Current Oncology (Toronto, Ont.)|April 25, 2015
Use of bevacizumab as a first-line treatment for metastatic breast cancerL Manso, F Moreno, R Márquez, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER studyE López-Miranda, P Tolosa-Ortega, M A Perelló-Martorell, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal D'Urologie Et De Nephrologie|June 1, 1973
[Ureteral compressions in Crohn's disease]C Olier, M Malafosse, M Huguier, et al.
Annales D'Urologie|January 1, 1985
[Ureteral invagination caused by a fibroepithelial polyp of the ureter. Apropos of a case]S Haupert, A Janin-Mercier, L Camillieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Drug-induced thrombocytopenia induced by trastuzumab: a special challenge in a curable diseaseC Jara Sánchez, C Olier Gárate, J García-Donas Jiménez, et al.
Annales D'Urologie|January 1, 1985
[Ureteral endometriosis. Apropos of a bilateral form]S Haupert, A Janin-Mercier, S Martini, et al.
Journal D'Urologie Et De Nephrologie|June 1, 1973
[A further case of arteriovenous fistula of the renal pedicle after nephrectomy]L B Gibod, C Olier, J L Giraudel, et al.
Anales Del Sistema Sanitario De Navarra|January 30, 2008
[New treatments for renal carcinoma]J L Pérez-Gracia, J M López-Picazo, C Olier, et al.
Scientific Reports|February 20, 2021
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancerI Blancas, C Olier, V Conde, et al.
Current Oncology (Toronto, Ont.)|April 25, 2015
Use of bevacizumab as a first-line treatment for metastatic breast cancerL Manso, F Moreno, R Márquez, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER studyE López-Miranda, P Tolosa-Ortega, M A Perelló-Martorell, et al.
Pageof 3